MYGN

SEC source: 0001517026-22-000006 · edgardoc.xml · nonDerivative · entry 1

Verratti Mark · CIK 0001517026 · President, Mental Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,791

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022.

SEC source: 0001519749-22-000008 · edgardoc.xml · nonDerivative · entry 2

Hart Jayne B. · CIK 0001519749 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,475

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022.

SEC source: 0001519749-22-000008 · edgardoc.xml · nonDerivative · entry 1

Hart Jayne B. · CIK 0001519749 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 183,639

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022.

SEC source: 0001770252-22-000006 · edgardoc.xml · nonDerivative · entry 2

Lambert Nicole · CIK 0001770252 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,099

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022.

SEC source: 0001770252-22-000006 · edgardoc.xml · nonDerivative · entry 1

Lambert Nicole · CIK 0001770252 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 249,277

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022.

SEC source: 0001621899-22-000006 · edgardoc.xml · nonDerivative · entry 2

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 421,504

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022.

SEC source: 0001621899-22-000006 · edgardoc.xml · nonDerivative · entry 1

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 426,827

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022.

SEC source: 0000899243-22-012327 · doc4.xml · nonDerivative · entry 2

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,159,429

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022.

SEC source: 0000899243-22-012327 · doc4.xml · nonDerivative · entry 1

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,185,629

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022.

SEC source: 0001885862-22-000004 · edgardoc.xml · nonDerivative · entry 1

Wong Pamela · CIK 0001885862 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,178

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001853654-22-000004 · edgardoc.xml · nonDerivative · entry 1

Santa Eric · CIK 0001853654 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,710

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001843568-22-000004 · edgardoc.xml · nonDerivative · entry 1

Ancona Margaret · CIK 0001843568 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,160

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001843872-22-000006 · edgardoc.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,066

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001519749-22-000006 · edgardoc.xml · nonDerivative · entry 1

Hart Jayne B. · CIK 0001519749 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,116

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001770252-22-000004 · edgardoc.xml · nonDerivative · entry 1

Lambert Nicole · CIK 0001770252 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 251,446

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001517026-22-000004 · edgardoc.xml · nonDerivative · entry 1

Verratti Mark · CIK 0001517026 · President, Mental Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,873

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001621899-22-000004 · edgardoc.xml · nonDerivative · entry 1

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 430,460

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0000899243-22-011943 · doc4.xml · nonDerivative · entry 1

DIAZ PAUL J · CIK 0001194247 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,203,513

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001519749-22-000004 · edgardoc.xml · derivative · entry 6

Hart Jayne B. · CIK 0001519749 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,000 shares

Expires 2022-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable.

SEC source: 0001519749-22-000004 · edgardoc.xml · derivative · entry 5

Hart Jayne B. · CIK 0001519749 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,500 shares

Expires 2022-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable.

SEC source: 0001519749-22-000004 · edgardoc.xml · nonDerivative · entry 4

Hart Jayne B. · CIK 0001519749 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,878

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001519749-22-000004 · edgardoc.xml · nonDerivative · entry 3

Hart Jayne B. · CIK 0001519749 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,378

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F2 · shares: Represents shares of common stock received upon exercise of a stock option award.

SEC source: 0001519749-22-000004 · edgardoc.xml · nonDerivative · entry 2

Hart Jayne B. · CIK 0001519749 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,878

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001519749-22-000004 · edgardoc.xml · nonDerivative · entry 1

Hart Jayne B. · CIK 0001519749 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,878

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F2 · shares: Represents shares of common stock received upon exercise of a stock option award.

SEC source: 0001843872-22-000004 · edgardoc.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,828

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person on February 18, 2021. The restricted stock units granted on February 18, 2021 represent a contingent right to receive one share of the Company's common stock and vested 25% on February 25, 2022 and vests 25% on February 25, 2023, 25% on February 25, 2024, and 25% on February 25, 2025. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 25, 2022.

SEC source: 0001843568-22-000002 · edgardoc.xml · nonDerivative · entry 1

Ancona Margaret · CIK 0001843568 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,406

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person on February 18, 2021. The restricted stock units granted on February 18, 2021 represent a contingent right to receive one share of the Company's common stock and vested 25% on February 25, 2022 and vests 25% on February 25, 2023, 25% on February 25, 2024, and 25% on February 25, 2025. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 25, 2022.

SEC source: 0001621899-22-000002 · edgardoc.xml · nonDerivative · entry 2

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 393,594

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 18, 2022.

SEC source: 0001621899-22-000002 · edgardoc.xml · nonDerivative · entry 1

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 404,774

F1 · kind: Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on March 24, 2021, subject to accomplishment of pre-determined performance metrics. On February 16, 2022, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on March 24, 2022, 25% on March 24, 2023, 25% on March 24, 2024, and 25% on March 24, 2025.

SEC source: 0001885862-22-000002 · edgardoc.xml · nonDerivative · entry 1

Wong Pamela · CIK 0001885862 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,825

F1 · kind: Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on October 18, 2021, subject to accomplishment of pre-determined performance metrics. On February 16, 2022, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on October 18, 2022, 25% on October 18, 2023, 25% on October 18, 2024, and 25% on October 18, 2025.

SEC source: 0001853654-22-000002 · edgardoc.xml · nonDerivative · entry 1

Santa Eric · CIK 0001853654 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,472

F1 · kind: Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on April 1, 2021, subject to accomplishment of pre-determined performance metrics. On February 16, 2022, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on April 1, 2022, 25% on April 1, 2023, 25% on April 1, 2024, and 25% on April 1, 2025.

SEC source: 0001843872-22-000002 · edgardoc.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,693

F1 · kind: Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on March 24, 2021, subject to accomplishment of pre-determined performance metrics. On February 16, 2022, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on March 24, 2022, 25% on March 24, 2023, 25% on March 24, 2024, and 25% on March 24, 2025.

SEC source: 0001519749-22-000002 · edgardoc.xml · nonDerivative · entry 1

Hart Jayne B. · CIK 0001519749 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,878

F1 · kind: Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on March 24, 2021, subject to accomplishment of pre-determined performance metrics. On February 16, 2022, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on March 24, 2022, 25% on March 24, 2023, 25% on March 24, 2024, and 25% on March 24, 2025.

SEC source: 0001770252-22-000002 · edgardoc.xml · nonDerivative · entry 1

Lambert Nicole · CIK 0001770252 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,781

F1 · kind: Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on March 24, 2021, subject to accomplishment of pre-determined performance metrics. On February 16, 2022, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on March 24, 2022, 25% on March 24, 2023, 25% on March 24, 2024, and 25% on March 24, 2025.

SEC source: 0001517026-22-000002 · edgardoc.xml · nonDerivative · entry 1

Verratti Mark · CIK 0001517026 · President, Mental Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,635

F1 · kind: Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on March 24, 2021, subject to accomplishment of pre-determined performance metrics. On February 16, 2022, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on March 24, 2022, 25% on March 24, 2023, 25% on March 24, 2024, and 25% on March 24, 2025.

SEC source: 0000899243-22-007020 · doc4.xml · nonDerivative · entry 1

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,030,369

F1 · kind: Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on March 24, 2021, subject to accomplishment of pre-determined performance metrics. On February 16, 2022, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on March 24, 2022, 25% on March 24, 2023, 25% on March 24, 2024, and 25% on March 24, 2025.

SEC source: 0001770252-21-000019 · edgardoc.xml · nonDerivative · entry 1

Lambert Nicole · CIK 0001770252 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,486

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments on January 1, 2023, January 1, 2024, January 1, 2025, and January 1, 2026.

F2 · balance_after: Includes 317 shares of Myriad common stock that were omitted from the reporting person's Form 3, which was amended to reflect such shares on November 1, 2021.

SEC source: 0001519749-21-000019 · edgardoc.xml · nonDerivative · entry 1

Hart Jayne B. · CIK 0001519749 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,358

F1 · kind: These shares were acquired under the Myriad Genetics, Inc. 2012 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

SEC source: 0001885862-21-000004 · edgardoc.xml · nonDerivative · entry 1

Wong Pamela · CIK 0001885862 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,753

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001517026-21-000009 · edgardoc.xml · nonDerivative · entry 2

Verratti Mark · CIK 0001517026 · President, Myriad Neuroscience

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,019

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock October 8, 2021.

SEC source: 0001517026-21-000009 · edgardoc.xml · nonDerivative · entry 1

Verratti Mark · CIK 0001517026 · President, Myriad Neuroscience

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,010

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021.

SEC source: 0001621899-21-000013 · edgardoc.xml · nonDerivative · entry 2

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 356,765

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock October 8, 2021.

SEC source: 0001621899-21-000013 · edgardoc.xml · nonDerivative · entry 1

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 364,184

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021.

SEC source: 0001219036-21-000031 · edgardoc.xml · nonDerivative · entry 2

LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,324

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock October 8, 2021.

SEC source: 0001219036-21-000031 · edgardoc.xml · nonDerivative · entry 1

LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,794

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021.

SEC source: 0001770252-21-000015 · edgardoc.xml · nonDerivative · entry 2

Lambert Nicole · CIK 0001770252 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,169

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock October 8, 2021.

SEC source: 0001770252-21-000015 · edgardoc.xml · nonDerivative · entry 1

Lambert Nicole · CIK 0001770252 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,639

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021.

SEC source: 0001519749-21-000017 · edgardoc.xml · nonDerivative · entry 2

Hart Jayne B. · CIK 0001519749 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,215

F3 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock October 8, 2021.

SEC source: 0001519749-21-000017 · edgardoc.xml · nonDerivative · entry 1

Hart Jayne B. · CIK 0001519749 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,163

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021.

F2 · balance_after: Includes 41,021 shares of Myriad common stock that were omitted from the reporting person's Form 3, which was amended to reflect such shares on October 12, 2021.

SEC source: 0001843872-21-000015 · edgardoc.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,173

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021.

SEC source: 0001770252-21-000013 · edgardoc.xml · nonDerivative · entry 1

Lambert Nicole · CIK 0001770252 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,652

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.91 to $32.01, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.